000			01741 a2200445 4500
005			20250515125608.0
264		0	_c20081015
008			200810s 0 0 eng d
022			_a0014-2999
024	7		_a10.1016/j.ejphar.2008.06.080 _2doi
040			_aNLM _beng _cNLM
100	1		_aLi, Na
245	0	0	_aEndothelin receptor antagonist CPU0213 and vitamin E reverse downregulation of FKBP12.6 and SERCA2a: a role of hyperphosphorylation of PKCepsilon. _h[electronic resource]
260			_bEuropean journal of pharmacology _cSep 2008
300			_a211-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntioxidants _xpharmacology
650	0	4	_aBiomarkers, Pharmacological _xmetabolism
650	0	4	_aCalcium _xmetabolism
650	0	4	_aDeath, Sudden, Cardiac _xprevention & control
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aEndothelin Receptor Antagonists
650	0	4	_aGene Expression Regulation _xdrug effects
650	0	4	_aHeart Failure _xdrug therapy
650	0	4	_aMyocytes, Cardiac _xdrug effects
650	0	4	_aPhosphorylation
650	0	4	_aProtein Kinase C-epsilon _xdrug effects
650	0	4	_aPyrazoles _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSarcoplasmic Reticulum Calcium-Transporting ATPases _xdrug effects
650	0	4	_aTacrolimus Binding Proteins _xdrug effects
650	0	4	_aVitamin E _xpharmacology
700	1		_aJia, Nan
700	1		_aDai, De-Zai
700	1		_aDai, Yin
773	0		_tEuropean journal of pharmacology _gvol. 591 _gno. 1-3 _gp. 211-8
856	4	0	_uhttps://doi.org/10.1016/j.ejphar.2008.06.080 _zAvailable from publisher's website
999			_c18093120 _d18093120